Norton Rose Fulbright Expands IP Practice with Addition of New Partner

Thursday, March 19, 2026iiplaeditorialSource: IIPLA
norton-rose-fulbright-expands-ip-practic.png
Source attribution
Image: Image courtesy of iipla.org

Norton Rose Fulbright Expands IP Practice with Addition of New Partner

By Editorial Team

March 19, 2026, 9:03 PM UTC

Norton Rose Fulbright has strengthened its intellectual property practice in Minneapolis with the appointment of Stuart Nelson as a partner, the firm announced on Monday.

Nelson brings a wealth of experience in advising both emerging companies and global enterprises on patent prosecution, strategic counseling, portfolio development, and post-grant disputes. His arrival enhances the firm's capability to provide comprehensive intellectual property counsel, spanning from early-stage portfolio development to enforcement, licensing, and disputes within technology-driven industries.

Prior to joining Norton Rose Fulbright, Nelson was associated with Fish & Richardson.

This news was originally reported by Bloomberg Law Automation.

For more information and in-depth legal analysis, subscribers can access Bloomberg Law for breaking news and insights.

Copyright © 2026 Bloomberg Industry Group, Inc. All Rights Reserved.

Related Coverage

Continue in the newsroom

Back to newsroom
IP News

Purple Rain Co-Star Ends Apollonia Trademark Rights Suit

‘Purple Rain’ Co-Star Ends ‘Apollonia’ Trademark Rights Suit By Editorial Team Patty Apollonia Kotero, known for her role as Prince’s co-star in the iconic 1984 film “Purple Rain,” has decided to drop her lawsuit agai...

Thursday, April 9, 2026
IP News

Federal Circuit Grills Sanctioned Patent Lawyer Over Conduct

Federal Circuit Grills Sanctioned Patent Lawyer Over Conduct By Editorial Team A Houston-based patent attorney faced a tough Federal Circuit bench while seeking to wipe out a $207,000 sanction against him and his clie...

Thursday, April 9, 2026
IP News

J&J Defends Blood-Clotting Powder IP From Baxter Attack

J&J Defends Blood-Clotting Powder IP From Baxter Attack By Editorial Team A subsidiary of Johnson & Johnson has successfully defended its patent for a hemostatic powder used to treat bleeding against objections from B...

Thursday, April 9, 2026